Table 5.
Laboratory features at baseline and during the 12-months study period in the ANA-treated patients.
| Laboratory | Baseline (n = 140) (%) | 3 months (n = 118) (%) | 6 months (n = 109) (%) | 12 months (n = 97) (%) | |
|---|---|---|---|---|---|
| Ferritin | |||||
| >200 ng/ml | 67.8 | 21.6 | 8.4 | 7.3 | |
| >1000 ng/ml | 47.1 | 9.2 | 2.4 | 2.9 | |
| >3000 ng/ml | 28.5 | 3 | 1.2 | 0 | |
| >10000 ng/ml | 10 | 0 | 0 | 0 | |
| Eritrocyte sedimentation rate (ESR) | 85 | 32.1 | 9.1 | 8.2 | |
| C-reactive protein (CRP) | 90 | 30.5 | 12.8 | 8.2 | |
| Augmented liver enzymes | 32.8 | 5 | 6.4 | 3 | |